International cohort study of colorectal cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The ColoCare Study is a multicenter, international prospective cohort initiative focused on patients diagnosed with stage I-IV colorectal cancer. It aims to establish a comprehensive database of clinical outcomes, including disease-free and overall survival, predictors of cancer recurrence, and treatment toxicities. Patients aged 18-89 years are recruited at the time of their first diagnosis and followed for up to five years, with regular assessments and specimen collection. The study also includes cross-sectional analyses of biomarkers and health behaviors to better understand the disease.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age 18-89 years; for patients recruited after 09/01/2021 the age range is 18-69 years. Recruitment of patients 70 years and older was maintained for specific sub-studies and re-initiated for specific R01 grant funding in \~06/2024
2. Men and women
3. Newly-diagnosed colon or rectal cancer (stages I-IV); CRC in treatment (FHCRC and HCI)
4. English (FHCRC, Moffitt, HCI, Cedars-Sinai, WashU St. Louis) or German (University Hospital Heidelberg)-speaking;
5. mentally/physically able to consent and participate.

Exclusion Criteria:

* if one of the above in not fulfilled
* insufficient language or consent capacity

Where it's running

• Cedars-Sinai Medical Center
  Los Angeles, California, United States Recruiting
• Lee H. Moffitt Cancer Center
  Tampa, Florida, United States Recruiting
• Washington University School of Medicine
  St Louis, Missouri, United States Recruiting
• University of Tennessee
  Knoxville, Tennessee, United States Recruiting
• Huntsman Cancer Institute
  Salt Lake City, Utah, United States Recruiting
• Fhcrc
  Seattle, Washington, United States Recruiting

Study contacts

• Principal investigator: Cornelia M Ulrich, MS, PhD — Huntsman Cancer Institute
• Study coordinator: Cornelia Ulrich, MS, PhD
• Email: neli.ulrich@hci.utah.edu
• Phone: (801) 213-5716

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Knife-assisted full-thickness resection for rectal lesions in a multicenter setting

  A multicenter study tests knife-assisted full-thickness resection (kFTR) to remove rectal lesions in adults and see how well it works and how safe it is.

  Recruiting University Hospital, Ghent · Ghent · NCT07923682

• Personalized 3D Bioprinted Colorectal Cancer Microenvironment Model

  This study tests patient-derived, 3D-bioprinted cancer models that include tumor, fibroblast, and immune cells to see if they can better predict how colorectal cancer will respond to treatment.

  Recruiting Peking Union Medical College Hospital · Ningbo, Zhejiang · NCT07919418

• Integrated genomic and clinical database for cancer biomarker discovery

  Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.

  Recruiting Samsung Medical Center · Seoul, Gang-Nam · NCT07911267

• Prehabilitation with Resistance, Aerobic, or Both Before Colorectal Surgery

  Four pre-surgery exercise options (resistance, aerobic, both, or none) will be tested to see which best reduces complications after colorectal cancer surgery.

  Recruiting Semmelweis University · Budapest · NCT07896174

• Liver transplantation for colorectal cancer with liver metastases

  This study follows adults with stage IV colorectal cancer whose disease is limited to the liver and who are getting a liver transplant as part of their cancer care to see how they fare over time.

  Recruiting Pontificia Universidad Catolica de Chile · Santiago, Santiago Metropolitan · NCT07884110

• LTZ-232: a first-in-human test in advanced colorectal and other solid tumors

  A first-in-human study tests LTZ-232, a new therapy for adults with unresectable or metastatic colorectal cancer and other solid tumors that have not responded to standard treatments.

  Recruiting Phase 1 LTZ Therapeutics, Inc. · Scottsdale, Arizona · NCT07878988

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.